Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

ACER3

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Alkaline ceramidase 3(ACER3) is a membrane-bound hydrolase encoded by ACER3 gene and located in endoplasmic reticulum and Golgi apparatus. It plays a catalytic role in alkaline environment, mainly distributed in glial cells, intestinal epithelium and placental tissues, and specifically degrades C18:1, C20:1 and other unsaturated long-chain ceramides. Compared with ACER1 and ACER2 in the same family, ACER3 has more unique substrate specificity, which can hydrolyze unsaturated ceramide with pro-apoptosis and pro-inflammatory effects to generate sphingosine, providing a precursor for downstream lipid S1P to produce anti-proliferation signal. Under normal physiological conditions, ACER3 can maintain the steady state of cell proliferation and inhibit the basic inflammatory reaction by scavenging toxic ceramide. The mutation of ACER3 function loss will lead to the abnormal accumulation of C18:1 ceramide in the central myelin sheath, which will lead to progressive white matter lesions in children. The decrease of ACER3 expression in intestinal tract will lead to the accumulation of mucosal ceramide, aggravate intestinal inflammation and promote the occurrence of inflammation-related colorectal cancer. Because other ceramidase can not replace the specific hydrolysis function of ACER3 on unsaturated ceramide, up-regulating ACER3 can effectively alleviate lipid-mediated neuroinflammation and inhibit the development of intestinal tumors, making it a key target for targeted research on sphingolipid metabolic enzymology, degenerative diseases and intestinal diseases.

ACER3 relies on the membrane structure of endoplasmic reticulum-Golgi apparatus to play the role of alkaline hydrolase, and specifically recognizes unsaturated long-chain ceramides through the conserved zinc ion catalytic domain, and has no obvious catalytic effect on saturated lipids. This unique substrate selection makes it clearly distinguished from ACER1 and ACER2, and it is a key functional protein that specifically removes inflammation-related lipids in nerve and intestinal tissues. ACER3-mediated ceramide -S1P metabolic transformation can link lipid toxic stress with inflammatory signal, and dynamically regulate cell survival and tissue inflammatory state according to the accumulation level of sphingolipids in the body. This protein is involved in many physiological and pathological processes such as central myelin homeostasis maintenance, intestinal mucosal immune regulation and colorectal cancer inhibition. The lack of catalytic activity of ACER3 will lead to the accumulation of toxic ceramides and induce persistent tissue inflammation, which is an important research object for sphingolipid metabolism research and disease targeted screening.

Fig. 1 Time-series sphingolipid metabolic enzyme schematic for Alzheimer's disease research, suitable for ACER3/CERS/SGMS recombinant protein, detection antibody and neural cell functional assays. (OA Literature)Fig. 1 Time-dependent sphingolipid enzyme changes in V717I AβPP mice following experimental pathway modulation.1

ACER3 Protein Function: Core Roles in Unsaturated Ceramide Hydrolysis and Lipid Anti-Inflammatory Tuning

The biological functions of ACER3 are fully focused on selective unsaturated ceramide cleavage and sphingosine generation:

  • Catalytic function of alkaline hydrolysis: As an alkaline ceramide hydrolase, it preferentially catalyzes the degradation of C18:1 and C20:1 subtypes of unsaturated long-chain ceramides, which has strict substrate specificity and is different from other isoenzymes in the same family.
  • Pro-inflammatory lipid scavenging effect: effectively remove toxic ceramide accumulation in cells, block the activation of NF-κB inflammatory signal pathway mediated by ceramide, and inhibit the basic inflammatory response of the body.
  • Regulation function of intestinal tumor: Down-regulation of ACER3 expression will break the homeostasis of intestinal lipid metabolism, aggravate the inflammatory reaction of intestinal mucosa, and significantly accelerate the malignant transformation process related to colitis.
  • Disease-related characteristics: ACER3 gene mutation can induce progressive leukodystrophy in children; The low expression of this gene is an important inducement for the progress of chronic intestinal inflammation and related diseases.

ACER3 Protein Product

Creative Biolabs offers high-quality ACER3 proteins through optimized eukaryotic expression systems, including full-length ER/Golgi dual-localized enzyme and isolated catalytic domain variants. These products retain native unsaturated ceramide hydrolytic activity, suitable for sphingolipid metabolic inhibitor screening assays. All ACER3 proteins undergo strict quality control to ensure consistent performance across lipid research platforms.

ACER3 Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

ACER3 Stable Cell Line Product

Creative Biolabs provides custom-engineered ACER3 stable cell lines, including wild-type overexpression and blank empty vector control models. These cell lines are optimized for alkaline ceramidase profiling and sphingolipid inflammatory signal functional analysis. Each cell line undergoes stringent validation to ensure stable expression profiles during long-term neural epithelial cell culture, and can be deployed for neuroprotective compound screening workflows.

ACER3 Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

ACER3 Recombinant Antibody Product

High-specificity recombinant antibodies targeting ACER3 are developed via advanced antibody engineering technologies, with no cross-reactivity with ACER1/2 isoforms. These antibodies are validated for ER/Golgi membrane localization detection and brain/colon tissue expression profiling, and can be combined with ceramide metabolic marker reagents to analyze sphingolipid turnover complexes in glial cell models.

ACER3 Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Native Unsaturated Ceramide Hydrolase Activity: Preserves intact alkaline catalytic capacity for sphingolipid research.
  • ACER3 Isoform Specificity: Eliminates non-specific cross-recognition of ACER1 and ACER2 paralogs.
  • Neuro-Gastro Compatibility: Optimized reagent series for leukodystrophy and inflammatory bowel disease screening workflows.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address sphingolipid research demands.

Custom ACER3 Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for ACER3 research:

  • Custom ACER3 Protein Production: Tailored expression of mutant and tagged ACER3 constructs for ceramide substrate kinetic analysis.
  • Custom Antibody Development: Generation of ACER3-specific antibodies for Golgi/ER immunostaining.
  • Stable Cell Line Engineering: Construction of ACER3-modified glial/intestinal cell models.
  • Functional Assay Development: Custom design of ceramide degradation detection workflows.

Frequently Asked Questions (FAQ)

  1. What is the primary function of ACER3?

    ACER3 is an ER/Golgi alkaline ceramidase that selectively degrades pro-inflammatory unsaturated long-chain ceramides into sphingosine.

  2. Why is ACER3 a significant research target?

    Loss-of-function ACER3 variants cause hereditary leukodystrophy, while intestinal ACER3 regulates colitis and colorectal cancer progression.

  3. Are Creative Biolabs' ACER3 products suitable for clinical use?

    No, all ACER3 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of ACER3 products does Creative Biolabs offer?

    Offerings include full-length ACER3 lipid enzymes, isoform-specific detection antibodies and custom stable cell lines for sphingolipid research.

  5. How are ACER3 proteins validated for activity?

    ACER3 proteins are validated via C18:1 ceramide hydrolytic catalytic functional testing.

Reference
  1. Jęśko, Henryk, et al. "Fingolimod affects transcription of genes encoding enzymes of ceramide metabolism in animal model of Alzheimer's disease." Molecular Neurobiology 57.6 (2020): 2799-2811. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.1007/s12035-020-01908-3
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
;